CoChat

A Randomized Placebo Controlled Clinical Trial to Determine the Impact of Digestion Resistant Starch MSPrebiotic® on Glucose, Insulin, and Insulin Resistance in Elderly and Mid-Age Adults

Open access
Alfa, Michelle J., Strang, David, Tappia, Paramjit S., Olson, Nancy, DeGagne, Pat, Bray, David, Murray, Brenda-Lee, Hiebert, Brett · 2018 · Frontiers in Medicine
Cited by 46

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Introduction: Type 2 Diabetes (T2D) has reached epidemic proportions in North America. Recent evidence suggests that prebiotics can modulate the gut microbiome, which then plays an important role in regulating lipid metabolism, blood glucose, and insulin sensitivity. As such, prebiotics are appealing potential therapeutic strategies for pre-diabetes and T2D. The key objectives of this study were to determine the tolerability as well as the glucose and insulin modulating ability of MSPrebiotic® digestion resistant starch in healthy middle aged and elderly adults. Materials and Methods: This was a prospective, blinded, placebo controlled study. Pre-diabetes and diabetes were among the exclusion factors. Elderly (>70 years) and mid-age (30 to 50 years) Canadian adults were recruited and, after 2 weeks of consuming placebo, they were randomized to consume 30 grams of either MSPrebiotic® or placebo per day for 12 weeks. In total, 42 elderly and 42 mid-age participants completed the study. Blood samples were collected over the 14 week study and analyzed for glucose, lipid profile, and CRP, lipid particles, TNF-α, IL-10, insulin and insulin resistance. Results: At baseline, the elderly population had a significantly higher percentage (p <0.01) with elevated glucose and significantly higher TNF-α (p < 0.01) compared to mid-age adults. MSPrebiotic® digestion resistant starch was well tolerated in both mid-age and elderly adults. There was a significant difference over time in blood glucose (p = 0.0301) and insulin levels (p = 0.009), as well as insulin resistance (HOMA-IR; p = 0.009) in elderly adults who consumed MSPrebiotic® compared to placebo. No significant changes were found in mid-age adults. Conclusions: Our results suggest that dietary supplementation with prebiotics such as MSPrebiotic® may be part of an effective strategy to reduce insulin resistance, a major risk factor for developing T2D, in the elderly.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmed.2017.00260

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

Metadata

Authors
Alfa, M. J., Strang, D., Tappia, P. S., Olson, N., DeGagne, P., Bray, D., Murray, B.-L., & Hiebert, B.
Venue
Frontiers in Medicine
Published
2018-01-22
Volume
4
Pages
260-260
ISSN
2296-858X (ISSN-L)
OpenAlex
W2791032754
Cited by
46
References
9
FWCI
3.07
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.